• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The appropriate elicitation of expert opinion in economic models: making expert data fit for purpose.

作者信息

Sullivan William, Payne Katherine

机构信息

ScHARR, The University of Sheffield, Sheffield, South Yorkshire, UK.

出版信息

Pharmacoeconomics. 2011 Jun;29(6):455-9. doi: 10.2165/11589220-000000000-00000.

DOI:10.2165/11589220-000000000-00000
PMID:21568356
Abstract
摘要

相似文献

1
The appropriate elicitation of expert opinion in economic models: making expert data fit for purpose.经济模型中专家意见的恰当引出：使专家数据适用于特定目的。
Pharmacoeconomics. 2011 Jun;29(6):455-9. doi: 10.2165/11589220-000000000-00000.
2
Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.基于模型的经济评估中专家判断使用的报告指南。
Pharmacoeconomics. 2016 Nov;34(11):1161-1172. doi: 10.1007/s40273-016-0425-9.
3
A comparison of two methods for expert elicitation in health technology assessments.卫生技术评估中两种专家意见征集方法的比较。
BMC Med Res Methodol. 2016 Jul 26;16:85. doi: 10.1186/s12874-016-0186-3.
4
An expert on every street corner? Methods for eliciting distributions in geographically dispersed opinion pools.每个街角都有专家？在地域分散的意见池中获取分布的方法。
Value Health. 2013 Mar-Apr;16(2):434-7. doi: 10.1016/j.jval.2012.10.011. Epub 2013 Jan 29.
5
The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.健康研究中计算建模研究中使用专家 elicitation：系统评价。
Med Decis Making. 2022 Jul;42(5):684-703. doi: 10.1177/0272989X211053794. Epub 2021 Oct 25.
6
EXPLICIT: a feasibility study of remote expert elicitation in health technology assessment.明确性：卫生技术评估中远程专家意见征集的可行性研究。
BMC Med Inform Decis Mak. 2017 Sep 4;17(1):131. doi: 10.1186/s12911-017-0527-0.
7
Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: Application to the IMPROVE trial.针对存在健康结局缺失情况的随机对照试验，开发一种实用的专家意见征集方法：在IMPROVE试验中的应用。
Clin Trials. 2017 Aug;14(4):357-367. doi: 10.1177/1740774517711442. Epub 2017 Jul 4.
8
Co-designing a Structured Expert Elicitation with Clinicians to Enhance Health Care Decision Making in Exercise Oncology.与临床医生共同设计结构化专家意见征集，以加强运动肿瘤学中的医疗保健决策。
Med Decis Making. 2025 Jul;45(5):602-613. doi: 10.1177/0272989X251332967. Epub 2025 Apr 25.
9
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.制定医疗保健决策中结构化专家 elicitation 的参考协议：混合方法研究。
Health Technol Assess. 2021 Jun;25(37):1-124. doi: 10.3310/hta25370.
10
Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.利用成本效益建模为报销决策提供信息：生成启发式先验以捕捉模型不确定性的过程指南。
Pharmacoeconomics. 2017 Sep;35(9):867-877. doi: 10.1007/s40273-017-0525-1.

引用本文的文献

1
Capturing the Impact of Constraints on the Cost-Effectiveness of Cell and Gene Therapies: A Systematic Review.捕捉约束对细胞和基因治疗的成本效益的影响：系统评价。
Pharmacoeconomics. 2023 Jun;41(6):675-692. doi: 10.1007/s40273-022-01234-7. Epub 2023 Mar 11.
2
Where is genetic medicine headed? Exploring the perspectives of Canadian genetic professionals on future trends using the Delphi method.遗传医学的未来走向如何？运用德尔菲法探索加拿大遗传专业人士对未来趋势的看法。
Eur J Hum Genet. 2022 May;30(5):496-504. doi: 10.1038/s41431-021-01017-2. Epub 2022 Jan 15.
3
Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine.

本文引用的文献

1
Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom.了解晚期结直肠癌患者的化疗治疗途径，为英国的经济评估提供信息。
Br J Cancer. 2010 Jul 27;103(3):315-23. doi: 10.1038/sj.bjc.6605766.
2
Fish and chips all round? Regulation of DNA-based genetic diagnostics.
Health Econ. 2009 Nov;18(11):1233-6. doi: 10.1002/hec.1553.
3
Characterizing structural uncertainty in decision analytic models: a review and application of methods.刻画决策分析模型中的结构不确定性：方法回顾与应用。
量化经济评估中容量限制的影响：精准医学的应用。
Med Decis Making. 2022 May;42(4):538-553. doi: 10.1177/0272989X211053792. Epub 2021 Oct 25.
4
Health and economic outcomes of newborn screening for infantile-onset Pompe disease.新生儿筛查婴儿型庞贝病的健康和经济结果。
Genet Med. 2021 Apr;23(4):758-766. doi: 10.1038/s41436-020-01038-0. Epub 2020 Dec 7.
5
Structuring a conceptual model for cost-effectiveness analysis of frailty interventions.构建衰弱干预措施成本效益分析的概念模型。
PLoS One. 2019 Sep 11;14(9):e0222049. doi: 10.1371/journal.pone.0222049. eCollection 2019.
6
Incremental cost and health gains of the 2016 WHO antenatal care recommendations for Rwanda: results from expert elicitation.卢旺达实施 2016 年世卫组织产前护理建议的增量成本和健康收益：专家意见调查结果。
Health Res Policy Syst. 2019 Apr 5;17(1):36. doi: 10.1186/s12961-019-0439-9.
7
Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.运用决策分析支持新生儿筛查政策决策：庞贝病案例研究
MDM Policy Pract. 2018 Jan-Jun;3(1). doi: 10.1177/2381468318763814. Epub 2018 Apr 18.
8
A Bayesian framework for health economic evaluation in studies with missing data.基于贝叶斯框架的缺失数据下健康经济评价研究。
Health Econ. 2018 Nov;27(11):1670-1683. doi: 10.1002/hec.3793. Epub 2018 Jul 3.
9
Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.利用成本效益建模为报销决策提供信息：生成启发式先验以捕捉模型不确定性的过程指南。
Pharmacoeconomics. 2017 Sep;35(9):867-877. doi: 10.1007/s40273-017-0525-1.
10
How Qualitative Methods Can be Used to Inform Model Development.定性方法如何用于指导模型开发。
Pharmacoeconomics. 2017 Jun;35(6):607-612. doi: 10.1007/s40273-017-0499-z.
Value Health. 2009 Jul-Aug;12(5):739-49. doi: 10.1111/j.1524-4733.2008.00502.x.
4
Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.将健康经济学建模整合到医疗设备产品开发周期中：一种贝叶斯方法。
Int J Technol Assess Health Care. 2008 Fall;24(4):459-64. doi: 10.1017/S0266462308080604.
5
Subgroups and heterogeneity in cost-effectiveness analysis.成本效益分析中的亚组与异质性
Pharmacoeconomics. 2008;26(9):799-806. doi: 10.2165/00019053-200826090-00009.
6
The value of implementation and the value of information: combined and uneven development.实施的价值与信息的价值：融合与不均衡发展
Med Decis Making. 2008 Jan-Feb;28(1):21-32. doi: 10.1177/0272989X07308751.
7
Value based pricing for NHS drugs: an opportunity not to be missed?英国国家医疗服务体系（NHS）药品的基于价值的定价：一个不容错过的机遇？
BMJ. 2008 Feb 2;336(7638):251-4. doi: 10.1136/bmj.39434.500185.25.
8
A critique and impact analysis of decision modeling assumptions.
Med Decis Making. 2007 Jul-Aug;27(4):491-9. doi: 10.1177/0272989X07300606.
9
Eliciting expert opinion for economic models: an applied example.获取经济模型的专家意见：一个应用实例。
Value Health. 2007 May-Jun;10(3):195-203. doi: 10.1111/j.1524-4733.2007.00169.x.
10
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment.卫生技术评估中决策分析模型的良好实践指南：质量评估的综述与整合
Pharmacoeconomics. 2006;24(4):355-71. doi: 10.2165/00019053-200624040-00006.